Showing 51-60 of 1319 results for "".
Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Migraine Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies/31511/With new—and first-in-class—migraine-specific treatments, preventive treatment of migraine is changing quickly.Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/37654/A review highlighting the clinical features of dementia and psychosis in people with Parkinson disease and diagnostic and therapeutic strategies for the management of these conditions.Advances from ACTRIMS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advances-from-actrims/30255/A single-track meeting creates more interaction opportunities that may lead to future advances.Disease Awareness: Multiple Sclerosis and Parkinson's
https://practicalneurology.com/columns/practice-management/disease-awareness-multiple-sclerosis-and-parkinsons/30781/Huntington's Disease: A Therapeutic Update
https://practicalneurology.com/diseases-diagnoses/movement-disorders/huntingtons-disease-a-therapeutic-update/30308/An expanding research and therapeutic landscape has increased awareness and treatment of Huntington's disease.Neuromodulation Strategies for Lennox-Gastaut Syndrome: A New Frontier
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neuromodulation-strategies-for-lennox-gastaut-syndrome-a-new-frontier/39964/The evolution of neuromodulation strategies for the management of Lennox- Gastaut syndrome emphasizes the role of targeted thalamic stimulation, the importance of individualized approaches, and the need for further research to optimize treatment efficacy.Toward Personalized Care for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/toward-personalized-care-for-multiple-sclerosis/31754/Biomarkers and precision medicine are just part of individualizing care for a diverse population of people with multiple sclerosis.Treatment of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/treatment-of-functional-movement-disorder/31885/All members of the treatment team must provide a unified message to a patient with functional movement disorder for treatment success.Calcitonin Gene-Related Peptide, Monoclonal Antibodies, and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies-and-migraine/30404/The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.